Regulation - Merck & Co

Filter

Current filters:

Merck & Co

Popular Filters

76 to 81 of 81 results

FDA panel gives unanimous backing for Merck & Co’s Vytorin for some kidney disease patients

04-11-2011

US drug giant Merck & Co (NYSE: MRK) said yesterday that the Endocrinologic and Metabolic Drugs Advisory…

Cardio-vascularMerck & CoNorth AmericaPharmaceuticalRegulationVytorin

FDA clears Merck & Co’s combo diabetes/cholesterol therapy Juvisync

10-10-2011

The US Food and Drug Administration on Friday approved the marketing of the first combination drug to…

Cardio-vascularDiabetesJanuviaJuvisyncMerck & CoNorth AmericaPharmaceuticalRegulationZocor

76 to 81 of 81 results

Back to top